Oncologic

2022-01-13 11:26 am

NF-κB inducing kinase (NIK) Novel target for cholangiocarcinoma

Molecular targeted drugs targeting the NIK associated with the differentiation factor from hepatocytes to cholangiocarcinoma

2021-10-13 16:47 pm

Target Discovery and Drug Evaluation using Cancer Stem Cells (CSCs)

We provide CSCs that can be subcultured for a long period of time, which have been enriched and purified from human cancer cells using our proprietary method. We propose joint research projects using these CSCs.

2021-07-14 16:47 pm

PeriCyto: A Companion Diagnostics for Immune Checkpoint Inhibitors

Prediction of the efficacy of cancer immunotherapy using the tumor-targeting activity of T cells in peripheral blood.

2021-07-02 16:19 pm

Interstitial Pneumonia Risk Diagnosis in Cancer Immunotherapy

Biomarkers for prediction and diagnosis of interstitial pneumonia, a side effect of cancer treatment with immune checkpoint inhibitors

2020-10-13 06:03 am

A whole-animal platform for exploring pancreatic cancer drug and combination therapy thereby

Drosophila models for human PDAC genotype

2019-07-26 07:47 am

Liver organoid model containing human hepatocytes for pharmacokinetic assay

Original method and hepatocyte reproduced hepatobiliary function

2018-04-16 05:09 am

Monoclonal Antibodies against Tumor Metastases

Against Peritoneal Dissemination, Lymph node/Liver metastases

2018-01-23 12:01 pm

DR6 Agonistic Antibody for SLE Therapy

DR6 mAb promotes Sdc1-DR6 dependent immunosuppressive pathway in autoreactive T cells

2017-07-21 13:29 pm

CKAP4-targeted Cancer Therapy

(Update): Anti-CKAP4 Monoclonal Antibody Obtained

2016-12-13 10:45 am

Anti-CD48 Monoclonal Antibody Drug for Multiple Myeloma

Cell Surface Antigen CD48 as A Novel Molecular Target for Antibody Therapy in Multiple Myeloma

2016-09-30 13:28 pm

Periostin hAbs for Triple Negative Breast Cancer, Other Diseases with Unmet Needs

Investment / Co-development Opportunity for Start-up Company